Jason R. Williams: How the Liver Microenvironment Shapes the Outcome of Cancer Metastasis
Jason R. Williams, Founder and Director of Interventional Oncology and Immunotherapy at Williams Cancer Institute, shared a post on X: “In the clinic I have seen a damaged liver heal on […]
Read the full articleYou might also wanna read
T cell-myeloid reprogramming overcomes immune resistance in colorectal cancer models
Mestrallet et al. show that T cell-myeloid interactions determine response to PD-1 blockade in colorectal cancer. Targeting TREM2 macrophage
Científicos financiados por los Institutos Nacionales de la Salud descubren pistas sobre las lesiones precancerosas y la biología tumoral
En nuevos estudios publicados por la Red del Atlas de Tumores Humanos (HTAN) del Instituto Nacional del Cáncer (NCI), se explora la función
FDA-approved drug may finally help immunotherapy defeat rare liver cancer
Researchers found that a rare liver cancer evades immunotherapy by luring immune T cells away from the tumor and trapping them in nearby fib
Gut microbiome composition predicts melanoma recurrence risk in patients on immunotherapy, large trial finds
In 674 high-risk melanoma patients across five regions, the gut microbiome differs by region but remains stable during ICB treatment, and re
Steatosis shapes prognosis-defining liver metastasis heterogeneity in CRC
Nature, Published online: 01 July 2026; doi:10.1038/s41586-026-10686-2 Liver steatosis increases formation of replacement liver metastases b
Scaling Organ-on-a-Chip Technology for Human-Relevant Drug Discovery
Learn how Organ-on-a-Chip technology supports human-relevant preclinical research and how Liver-Chip models can improve prediction of drug-i
Comments
Sign in to join the conversation.
No comments yet. Be the first.